483 results found

浙江大学によると...

On July 3, 2020, China's National People's Congress published the second draft of the latest amendment to China's Patent Law (the "Draft Amendment") for public comments, which were allowed to be submitted by August 16, 2020.

Since its enactment in 1984, China's Patent Law has been amended twice, first in 1992 and then in 2000. The first amendment added pharmaceutical compositions to the list of patentable subject matter and inaugurated China's membership in the Patent Cooperation Treaty ("PCT").

A patent corresponding to the generic drugs that have been marketed in China and registered on the Patent Information Registration Platform for Marketed Drugs...

Recently, an invention patent was granted, with a patent No. ZL202110172158.7 and issue No. CN113046327B, named "Pangolin Coronavirus xCoV and Application thereof and Application of Medicine...

The China National Intellectual Property Administration ("CNIPA") recently announced the "Revised Patent Examination Guidelines", which came into force from January 15, 2021.

2020年10月17日，专利法修订草案第三次送审稿通过了全国人大常委会审议，将于2021年6月1日起施行，本次专利法修改受到业内人士的广泛关注。

我国澳门特别行政区依托...

<<2021년 중국 지식재산권 보호 상황>>백서에 따르면 2021년 전국 지방 각급 인민법원은 지식재산권 1심 사건 550263건을 새로 접수하고 515861건을 심리종결하였는데 그

The first half of 2018 saw a number of significant changes to the Chinese anti-corruption regime, including amendments to the Anti-Unfair Competition Law and formation of new anti-corruption regulatory bodies.

2025 was a year of notable developments for China's life sciences industry, marked by significant revisions to major legislation and regulations.

原告广西宏桂汇康食品有限公司（"广西宏桂"）是一家国有企业...

In the age of globalization, Chinese pharmaceutical companies are at the forefront of innovation and collaboration, seizing unprecedented development opportunities.

China has proposed a new rule framing a drug patent linkage system that will have significant impact on multinational pharmaceutical companies doing business in China

National Food Security Standard (hereinafter referred to as the "National Standard") is crucial to anyone who works in the food industry.

Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision by the China's State Administration...

The Supreme People's Court ("SPC") of the People's Republic of China ("PRC") has recently promulgated the Interpretation on Several Issues Concerning the Application of Law to the Trial of Cases of Disputes over Punitive Damages in Food and Drugs ("Interpretation"), taking effect from August 22, 2024.